American Oncology Network, Inc. Warrant
AONCW
AONCW was delisted on the 7th of June, 2024.
46 hedge funds and large institutions have $707K invested in American Oncology Network, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
8% less funds holding
Funds holding: 50 → 46 (-4)
45% less capital invested
Capital invested by funds: $1.29M → $707K (-$583K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$950 |
| 2 |
HF
HRT Financial
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$2.25K |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.69K |
| 3 |
CAC
Cowen and Company
New York
|
-$1.02K |
| 4 |
FTUS
Flow Traders U.S.
New York
|
-$511 |
| 5 |
SC
Sculptor Capital
New York
|
-$238 |
AONCW Hedge Fund Activity: Q2 2023 in Review
46 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Warrant (AONCW) for Q2 2023, worth a combined $707K — down 45% from $1.29M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of AONCW and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $950. The largest seller was StoneX Group, exiting entirely with an estimated $2.25K sold.
- 46 institutional investors held American Oncology Network, Inc. Warrant (AONCW) as of Q2 2023, down from 50 in Q1 2023.
- Funds reported $707K of American Oncology Network, Inc. Warrant stock for Q2 2023, down 45% quarter-over-quarter.
- 1 fund opened new American Oncology Network, Inc. Warrant positions in Q2 2023 and 4 closed out, a net change of -3 holders.
- The largest American Oncology Network, Inc. Warrant buyer in Q2 2023 was Citadel Advisors, an estimated $950 added.
- The largest American Oncology Network, Inc. Warrant seller in Q2 2023 was StoneX Group, an estimated $2.25K sold.
Based on aggregated 13F filings for Q2 2023.